|
End-of-day quote
NSE India S.E.
2026-08-18
|
5-day change | 1st Jan Change | ||
| 247.50 INR | -2.00% |
|
-9.59% | +64.21% |
| 08-11 | Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 06-22 | Bafna Pharmaceuticals Limited Announces Board and Committee Changes | CI |
| Market Cap | 2.59B 27M 23.32M 21.94M 19.94M 37.5M 38.05M 257M 101M 1.29B 101M 99.16M 4.31B | P/E 2024 |
25.2x | P/E 2025 | 42.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.83B 29.58M 25.55M 24.04M 21.85M 41.09M 41.69M 282M 111M 1.42B 111M 109M 4.72B | EV / Sales 2024 |
1.37x | EV / Sales 2025 | 1.38x |
| Free-Float |
10.3% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.00% | ||
| 1 week | -9.59% | ||
| Current month | -5.86% | ||
| 1 month | +9.57% | ||
| 3 months | +82.93% | ||
| 6 months | +112.99% | ||
| Current year | +64.21% |
| 1 week | 247.5 |  | 262.95 |
| 1 month | 225 | | 290.7 |
| Current year | 94.77 | | 290.7 |
| 1 year | 91.2 | | 290.7 |
| 3 years | 69 | | 290.7 |
| 5 years | 69 | | 290.7 |
| 10 years | 4.4 | | 290.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 1980-12-31 | |
Melagiri Sridhar
DFI | Director of Finance/CFO | - | - |
| Compliance Officer | - | 2024-05-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2020-09-09 | |
| Director/Board Member | - | 2020-09-09 | |
| Chairman | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.00% | -9.59% | +115.42% | +117.97% | 62.49M | |
| -0.37% | -3.44% | +14.85% | +65.22% | 47.23B | |
| +0.96% | -0.78% | +49.09% | +125.01% | 39.62B | |
| -0.03% | -2.18% | -8.57% | +15.75% | 12.09B | |
| -1.41% | -6.33% | +13.09% | +72.20% | 11.8B | |
| +0.58% | 0.00% | +30.65% | +147.62% | 9.12B | |
| -0.54% | -0.84% | +22.33% | +40.09% | 7.57B | |
| -0.08% | +0.97% | +42.08% | -12.23% | 7.1B | |
| -1.03% | +1.27% | +16.77% | +200.84% | 6.87B | |
| -0.97% | -2.30% | -30.37% | +24.93% | 5.81B | |
| Average | -0.48% | -1.34% | +26.53% | +79.74% | 14.73B | |
| Weighted average by Cap. | -0.06% | -2.15% | +23.02% | +82.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.52B 15.91M 13.74M 12.93M 11.75M 22.1M 22.43M 152M 59.45M 763M 59.74M 58.45M 2.54B | 1.46B 15.22M 13.15M 12.37M 11.24M 21.15M 21.46M 145M 56.87M 729M 57.15M 55.91M 2.43B |
| Net income | 73.48M 767K 662K 623K 566K 1.07M 1.08M 7.31M 2.86M 36.75M 2.88M 2.82M 122M | 41.52M 433K 374K 352K 320K 602K 611K 4.13M 1.62M 20.77M 1.63M 1.59M 69.18M |
| Net Debt | 230M 2.4M 2.07M 1.95M 1.77M 3.33M 3.38M 22.88M 8.96M 115M 9.01M 8.81M 383M | 248M 2.58M 2.23M 2.1M 1.91M 3.59M 3.64M 24.64M 9.66M 124M 9.7M 9.49M 413M |
Employees
406
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | ₹247.50 | -2.00% | 5,177 |
| 26-08-17 | ₹252.55 | -2.00% | 2,815 |
| 26-08-14 | ₹257.70 | -2.00% | 618 |
| 26-08-13 | ₹262.95 | -1.99% | 2,145 |
| 26-08-12 | ₹268.30 | -1.99% | 3,321 |
- Stock Market
- Stocks
- BAFNAPH Stock
Select your edition
All financial news and data tailored to specific country editions
